EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Impact of leuprolide and goserelin on androgen suppression and adverse events in patients with prostate cancer

Carla Simone Moreira Freitas, Fabiana Rocha-Silva, Thaís Almeida Marques-Silva, Ana Carolina Ribeiro de Oliveira, Sérgio Gomes da Silva, Fabrizio Dos Santos Cardoso, Aleida Nazareth Soares

Canadian Journal of Urology · 2026 · 33 (4) · 827-839

DOI: 10.32604/cju.2026.069559 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Canadian Journal of Urology, 2026. Verfasst von Carla Simone Moreira Freitas und 6 weiteren Autor:innen. Beteiligte Einrichtung: Hospital do Câncer de Muriaé, Fundação Cristiano Varella (FCV), Muriaé, MG, Brazil. Hauptthemen laut MEDLINE: Leuprolide, Goserelin, Prostatic Neoplasms, Antineoplastic Agents, Hormonal.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LeuprolideGoserelinProstatic NeoplasmsAntineoplastic Agents, HormonalAndrogen AntagonistsHumansMaleProstate-Specific AntigenTestosteroneProspective StudiesAgedMiddle AgedHot FlashesAged, 80 and over

Stichwörter der Autor:innen

adverse eventsandrogen deprivation therapygenetic profileluteinizing hormone-releasing hormone (LHRH) agonistsprostate cancer

Substanzen

LeuprolideGoserelinProstate-Specific AntigenAntineoplastic Agents, HormonalTestosteroneAndrogen Antagonists

Autor:innen und Institutionen

  • Hospital do Câncer de Muriaé, Fundação Cristiano Varella (FCV), Muriaé, MG, Brazil.
  • Faculdade de Saúde Santa Casa BH, Belo Horizonte, MG, Brazil.
  • Centro Universitário Redentor-Afya (UNIREDENTOR-Afya), Itaperuna, RJ, Brazil.
  • Instituto D'Or de Ensino e Pesquisa (IDOR), Rio de Janeiro, RJ, Brazil.
  • Hospital São Vicente de Paulo (HSVP), Bom Jesus do Itabapoana, RJ, Brazil.

Zitieren

APA

Freitas, C. S. M., Rocha-Silva, F., Marques-Silva, T. A., de Oliveira, A. C. R., da Silva, S. G., Santos Cardoso, F. D., & Soares, A. N. (2026). Impact of leuprolide and goserelin on androgen suppression and adverse events in patients with prostate cancer. Canadian Journal of Urology, 33(4), 827-839. https://doi.org/10.32604/cju.2026.069559

Vancouver

Freitas CSM, Rocha-Silva F, Marques-Silva TA, de Oliveira ACR, da Silva SG, Santos Cardoso FD, et al. Impact of leuprolide and goserelin on androgen suppression and adverse events in patients with prostate cancer. Canadian Journal of Urology. 2026;33(4):827-839. doi:10.32604/cju.2026.069559

BibTeX
@article{Freitas2026,
  author = {Freitas, Carla Simone Moreira and Rocha-Silva, Fabiana and Marques-Silva, Thaís Almeida and de Oliveira, Ana Carolina Ribeiro and da Silva, Sérgio Gomes and Santos Cardoso, Fabrizio Dos and Soares, Aleida Nazareth},
  title = {Impact of leuprolide and goserelin on androgen suppression and adverse events in patients with prostate cancer},
  journal = {Canadian Journal of Urology},
  year = {2026},
  volume = {33},
  number = {4},
  pages = {827--839},
  doi = {10.32604/cju.2026.069559}
}
Kostenlos starten →